Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 8,713	$ 8,288
Fixed maturity securities (amortized cost of $26,200 and $25,879; allowance for credit losses of $13 and $6)	26,283	25,201
Equity securities	1,220	1,192
Premium receivables, net	9,535	8,011
Self-funded receivables, net	5,122	5,044
Other receivables	7,692	6,016
Other current assets	5,213	4,700
Assets held for sale	0	490
Total current assets	63,778	58,942
Long-term investments:
Fixed maturity securities (amortized cost of $1,110 and $1,049; allowance for credit losses of $$0 and $0)	1,111	1,035
Other invested assets	10,648	9,749
Property and equipment, net	4,657	4,652
Goodwill	28,451	28,277
Other intangible assets	11,327	12,094
Other noncurrent assets	2,777	2,140
Total assets	122,749	116,889
Current liabilities:
Medical claims payable	17,148	15,746
Other policyholder liabilities	2,447	4,204
Unearned income	1,831	1,508
Accounts payable and accrued expenses	6,085	6,927
Short-term borrowings	180	365
Current portion of long-term debt	749	1,649
Other current liabilities	12,438	10,029
Liabilities held for sale	0	153
Total current liabilities	40,878	40,581
Long-term debt, less current portion	31,173	29,218
Reserves for future policy benefits	164	190
Deferred tax liabilities, net	2,315	2,148
Other noncurrent liabilities	4,137	3,326
Total liabilities	78,667	75,463
Commitments and contingencies – Note 11
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares outstanding (in shares)	0	0
Shareholders’ equity
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none	$ 0	$ 0
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 222,036,187 and 227,479,695	2	2
Additional paid-in capital	8,908	8,911
Retained earnings	35,586	33,549
Accumulated other comprehensive loss	(543)	(1,147)
Total shareholders’ equity	43,953	41,315
Noncontrolling interests	129	111
Total equity	44,082	41,426
Total liabilities and equity	$ 122,749	$ 116,889

Elevance Health, Inc. 10-Q